Norwalk Leslie V
Neurocrine Biosciences, Inc. · Director
Norwalk Leslie V is listed in filings as Director at Neurocrine Biosciences, Inc.. This profile follows SEC Form 4 activity through Jun 8, 2026, including sale activity. Recent filings connect the profile to Neurocrine Biosciences, Inc. (NBIX), Globus Medical Inc (GMED), CVS Health Corp (CVS), and Arvinas, Inc. (ARVN). The current snapshot covers public activity from Jul 15, 2024 to Jun 8, 2026. Reported amounts are shown as $210.1K to $184.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $185k1.2k shares | SellDec 16, 2025 | $155.09 | $174.08 | |
| $761k5k shares | SellDec 15, 2025 | $152.23 | $174.08 | |
| $591k3.8k shares | SellMay 12, 2026 | $155.01 | $174.08 | |
| $70k1k shares | SellJul 11, 2024 | $70.00 | $78.56 | |
| $355k4k shares | SellDec 12, 2025 | $88.85 | $78.56 | |
| $202k2k shares | SellJan 8, 2026 | $101.10 | $78.56 |